Pharmacological interventions for depression in adults with chronic hepatitis B or C

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate the effectiveness and safety of pharmacological interventions for depression in adults with chronic hepatitis B or C.

This is a protocol.

Published:

10 August 2022

Authors:

Akhter Z, Todowede O, Brown JV, Jarde A, Mazhar L, narasimha Vl, Muhammad S, Fazid S, Rehman K, Deshmukh C, Ayinla A, Wuraola F, Ashraf MN, Siddiqi N

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Akhter Z, Todowede O, Brown JV, Jarde A, Mazhar L, narasimha Vl, Muhammad S, Fazid S, Rehman K, Deshmukh C, Ayinla A, Wuraola F, Ashraf MN, Siddiqi N. Pharmacological interventions for depression in adults with chronic hepatitis B or C (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 8. Art. No.: CD015037. DOI: 10.1002/14651858.CD015037.